We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+10.77%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$19.5B
AUM Growth
+$4.2B
(+27%)
Cap. Flow
+$3.06B
Cap. Flow
% of AUM
15.66%
Top 10 Holdings %
Top 10 Hldgs %
15.97%
Holding
1,184
New
406
Increased
253
Reduced
226
Closed
288
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$284M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
| 3 |
Eli Lilly
LLY
|
+$204M |
| 4 |
Meta Platforms (Facebook)
META
|
+$191M |
| 5 |
Microsoft
MSFT
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$205M |
| 2 |
Merck
MRK
|
+$169M |
| 3 |
Canadian National Railway
CNI
|
+$131M |
| 4 |
NXP Semiconductors
NXPI
|
+$119M |
| 5 |
Fidelity National Information Services
FIS
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.23% |
| 2 | Technology | 20.39% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 8.95% |
| 5 | Communication Services | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Aldeyra Therapeutics
ALDX
$95.3M
| $4.76M | 0.02% |
+641,918
| New | +$4.15M |
|
577
Seres Therapeutics
MCRB
$48.9M
| $4.71M | 0.02% |
+8,319
| New | +$2.77M |
|
578
Plains GP Holdings
PAGP
$4.98B
| $4.7M | 0.02% |
+771,853
| New | +$5.91M |
|
579
Prelude Therapeutics
PRLD
$365M
| $4.69M | 0.02% |
+155,690
| New | +$4.4M |
|
|
ENDP
580
DELISTED
Endo International plc
ENDP
| $4.68M | 0.02% |
+1,417,200
| New | +$4.55M |
|
581
Liberty Global Class A
LBTYA
$3.57B
| $4.62M | 0.02% |
+219,886
| New | +$4.94M |
|
582
Xylem
XYL
$28.4B
| $4.62M | 0.02% |
+54,900
| New | +$4.27M |
|
583
Smith & Nephew
SNN
$12.6B
| $4.58M | 0.02% |
117,091
+36,878
| +46% | +$1.48M |
|
584
Cal-Maine
CALM
$4.05B
| $4.53M | 0.02% |
+118,007
| New | +$4.99M |
|
585
Taysha Gene Therapies
TSHA
$1.8B
| $4.48M | 0.02% |
+200,000
| New | +$4.7M |
|
|
JKS
586
JinkoSolar
JKS
$813M
| $4.48M | 0.02% |
+112,631
| New | +$2.58M |
|
|
AMRN
587
Amarin Corp
AMRN
$301M
| $4.45M | 0.02% |
52,901
-2,531
| -5% | -$303K |
|
|
AKRO
588
DELISTED
Akero Therapeutics
AKRO
| $4.41M | 0.02% |
143,139
-301,893
| -68% | -$10.6M |
|
589
NVR
NVR
$16.8B
| $4.38M | 0.02% |
1,073
-3,154
| -75% | -$12.2M |
|
590
Knight Transportation
KNX
$11.6B
| $4.36M | 0.02% |
+107,037
| New | +$4.7M |
|
|
GAN
591
DELISTED
GAN Ltd
GAN
| $4.35M | 0.02% |
257,292
+64,666
| +34% | +$1.37M |
|
592
Telefônica Brasil
VIV
$19.4B
| $4.34M | 0.02% |
+565,306
| New | +$5.12M |
|
593
Lam Research
LRCX
$389B
| $4.33M | 0.02% |
+130,660
| New | +$4.5M |
|
594
Mattel
MAT
$4.25B
| $4.33M | 0.02% |
+369,949
| New | +$4.11M |
|
595
Magnolia Oil & Gas
MGY
$5.72B
| $4.29M | 0.02% |
+828,752
| New | +$5.16M |
|
|
KC
596
Kingsoft Cloud Holdings
KC
$3.82B
| $4.28M | 0.02% |
145,000
+105,778
| +270% | +$3.61M |
|
|
SOHU
597
Sohu.com
SOHU
$362M
| $4.24M | 0.02% |
+213,630
| New | +$3.71M |
|
598
Republic Services
RSG
$63.7B
| $4.24M | 0.02% |
45,425
-376,173
| -89% | -$33.6M |
|
|
VSLR
599
DELISTED
VIVINT SOLAR, INC.
VSLR
| $4.24M | 0.02% |
100,000
-1,067,198
| -91% | -$27.5M |
|
600
Entergy
ETR
$50.4B
| $4.21M | 0.02% |
85,400
-227,752
| -73% | -$11.3M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q3 2020 Portfolio in Review
As of Q3 2020, Point72 Asset Management held 1,184 positions worth $19.5B, up 27% from $15.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Point72 Asset Management deployed $3.06B of net new capital in Q3 2020, opening 406 new positions and adding to 253 existing holdings. Its largest new stake was Palantir: 29,904,230 shares worth $284M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Immunomedics Inc, an estimated $205M trimmed.
- Point72 Asset Management's largest Q3 2020 buy was Palantir: 29,904,230 shares worth $284M.
- Point72 Asset Management added most to Alphabet (Google) Class A in Q3 2020, an estimated $243M increase.
- Point72 Asset Management's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $205M.
- Point72 Asset Management fully exited Salesforce in Q3 2020, selling an estimated $105M.
- Point72 Asset Management's ten largest holdings make up 16% of its $19.5B portfolio in Q3 2020.
- Point72 Asset Management opened 406 new positions and closed 288 in Q3 2020.
- Point72 Asset Management's portfolio value rose 27% quarter-over-quarter to $19.5B.
Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.